Bladder cancer — all decisions

The Board remands the claim for service connection for residuals of bladder cancer to obtain a medical opinion regarding the Veteran's exposure to ionizing radiation and its potential link to his bladder cancer.

The Board denied the Veteran's claims for service connection for squamous cell carcinoma of the left ear and transurethral resection of bladder cancer as there was no evidence to support a finding that these conditions were related to his service, including any exposure to herbicides.

The Board denied an earlier effective date for the award of DIC based on service connection for the cause of the Veteran's death, as VA did not have a duty to send a DIC form until May 2023.

The Board granted a 100 percent rating for bladder cancer as of January 17, 2024, but denied a compensable rating prior to that date.

The Board granted service connection for bladder cancer, finding it to be related to the Veteran's in-service exposures.

The Board granted earlier effective dates of March 14, 2017, for service-connected erectile dysfunction, bladder cancer with acquired urinary incontinence and frequency of micturition, and special monthly compensation (SMC) based on loss of use of a creative organ.

The Board granted service connection for bladder cancer and diabetes mellitus, but remanded the issue of entitlement to service connection for prostate gland injuries with transurethral resection (TURP) postoperative residuals.

The appeal for an increased rating for bladder cancer was dismissed due to the untimely submission of a VA Form 10182. The claims for service connection for chronic kidney disease and fatty liver disease were remanded for further development.

The appeal concerning the issues of service connection for bladder cancer and impotency is dismissed due to the Veteran's death during the pendency of the appeal.

The Board granted service connection for COPD, bladder cancer, and a heart condition due to in-service exposure to asbestos and lead paint.

The Board granted service connection for bladder cancer based on the Veteran's exposure to herbicides in Thailand, as supported by the PACT Act.

The Board granted service connection for bladder cancer, finding new and relevant evidence that the Veteran was exposed to herbicides during his service on the USS Ticonderoga.

The Board granted service connection for type II diabetes, prostate cancer, and bladder cancer urothelial carcinoma based on the Veteran's exposure to contaminated water at Camp Lejeune.

The Board granted service connection for bladder cancer as secondary to the Veteran's already service-connected brain and lung cancers.

The Board dismissed the appeals for initial disability ratings and remanded claims related to diabetes mellitus, hypertension, and diabetic neuropathy due to a lack of evidence.

The Board remands the claim for service connection for bladder cancer to satisfy a regulatory or statutory duty related to the Veteran's alleged exposure to chemicals, including jet fuel and hydraulic fluid.

The Board granted service connection for bladder cancer based on new and relevant evidence showing the Veteran's exposure to herbicides during his service aboard the USS Ticonderoga.

The Board remands the claims for service connection for various conditions, including bilateral ankle disorders, diabetes mellitus, type II, a heart disorder, a right shoulder disorder, hypertension, a low back disorder, bladder cancer, and left and right lung disease, to obtain additional evidence regarding the Veteran's toxic exposure during service.

The Board granted service connection for a left shoulder disability, currently diagnosed as left shoulder strain and dislocation. The other claims were remanded.

The Board denied service connection for hypertension, coronary artery disease, congestive heart failure, carotid artery disease blockage with surgery, peripheral arterial disease, prostate cancer, bladder cancer, kidney cancer, and anxiety and depression as not being related to the Veteran's active duty or any herbicide exposure.